High baseline bilirubin and low albumin predict liver decompensation and serious adverse events in HCV-infected patients treated with sofosbuvir-containing regimens by Perumalswami, P. V., Patel, N., Bichoupan, K., Ku, L., Yalamanchili, R., Harty, A., Motamed, D., Khaitova, V., Chang, C., Grewal, P., Liu, L., Schiano, T. D., Woodward, M., Dieterich, D. T., Branch, A. D.

Get full text

P0881 : Real world effectiveness and cost of simeprevir- and/or sofosbuvir-based HCV treatments: $175,000 per SVR12 by Bichoupan, K, Tandon, N, Del Bello, D, Patel, N, Yalamanchili, R, Chekuri, S, Harty, A, Chang, S, Ku, L, Ng, M, Motamed, D.B, Sigel, K.M, Gardenier, D, Stivala, A, Khaitova, V, Bansal, M.B, Grewal, P, Agarwal, R, Chang, C.Y, Leong, J, Im, G.Y, Liu, L.U, Odin, J.A, Bach, N, Friedman, S.L, Schiano, T.D, Perumalswami, P, Dieterich, D.T, Branch, A.D

Get full text

795 REAL WORLD COSTS OF TELAPREVIR-BASED TRIPLE THERAPY, INCLUDING COSTS OF MANAGING ADVERSE EVENTS, AT THE MOUNT SINAI MEDICAL CENTER, NY: $147,000 PER EOT by Bichoupan, K, Martel-Laferriere, V, Ng, M, Schonfeld, E.A, Pappas, A, Crismale, J, Stivala, A, Khaitova, V, Gardenier, D, Perumalswami, P, Schiano, T.D, Odin, J.A, Liu, L, Dieterich, D.T, Branch, A.D

Get full text

Factors Associated With Failure Of Telaprevir- And Boceprevir-Based Hcv Triple Therapy by Bichoupan, K, Tandon, N, Martel-Laferriere, V, Sachs, D, Ng, M, Schonfeld, E.A, Pappas, A, Crismale, J, Stivala, A, Khaitova, V, Gardenier, D, Linderman, M, Olson, W, Perumalswami, P, Schiano, T.D, Odin, J.A, Liu, L.U, Dieterich, D.T, Branch, A.D

Get full text

PIN3 - Factors Associated With Failure Of Telaprevir- And Boceprevir-Based Hcv Triple Therapy by Bichoupan, K., Tandon, N., Martel-Laferriere, V., Sachs, D., Ng, M., Schonfeld, E.A., Pappas, A., Crismale, J., Stivala, A., Khaitova, V., Gardenier, D., Linderman, M., Olson, W., Perumalswami, P., Schiano, T.D., Odin, J.A., Liu, L.U., Dieterich, D.T., Branch, A.D.

Get full text

Role of Reactive Oxygen Species and Bcl-2 Family Proteins in TNF-α-Induced Apoptosis of Lymphocytes by Ryazanceva, N. V., Novickiy, V. V., Zhukova, O. B., Biktasova, A. K., Chechina, O. E., Sazonova, E. V., Belkina, M. V., Chasovskih, N. Yu, Khaitova, Z. K.

Get full text

Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection by Bichoupan, Kian, Tandon, Neeta, Martel-Laferriere, Valerie, Patel, Neal M, Sachs, David, Ng, Michel, Schonfeld, Emily A, Pappas, Alexis, Crismale, James, Stivala, Alicia, Khaitova, Viktoriya, Gardenier, Donald, Linderman, Michael, Olson, William, Perumalswami, Ponni V, Schiano, Thomas D, Odin, Joseph A, Liu, Lawrence U, Dieterich, Douglas T, Branch, Andrea D

Get full text

Role of Reactive Oxygen Species and Bcl-2 Family Proteins in TNF-[alpha]-Induced Apoptosis of Lymphocytes by Ryazanceva, N V, Novickiy, V V, Zhukova, O B, Biktasova, A K, Chechina, O E, Sazonova, E V, Belkina, M V, Chasovskih, N Yu, Khaitova, Z K

Get full text

Immunogenetic investigation of families with close intermarriage by Alekseev, L. P., Khaitova, N. M., Dmitrieva, N. G., Boldyreva, M. N., Kadyrova, R. T., Yazdovskii, V. V., Istamova, O. I.

Get full text